For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > Formulary Search > PAD Profile : Sirolimus - Angiofibroma from tuberous sclerosis complex
PAD Profile : Sirolimus - Angiofibroma from tuberous sclerosis complex
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
No drugs returned.
Other Indications
No indications returned.
Additional Documents
No additional documents returned.
Committee Recommendations
This drug has not yet been assessed for formulary status.
It has not yet been evaluated by NICE or the Surrey Heartlands ICS Area Prescribing Committee (APC). As such, advice regarding safety, effectiveness (including cost-effectiveness) and its place in therapy is yet to be determined. It is recommended that clinicians contact their medicines management team for further information and advice before prescribing this drug.
NICE are expected to publish guidance on this drug (date tbc) and this will be considered by the APC within 90 days of publication